| A Prospective Registry for Patients at High-Risk for Pancreatic Cancer (NCT06151223) | Mayo Clinic | 2021-07-13 |
| PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer (NCT05524090) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2021-07-01 |
| Early Palliative Care for Patients With Advanced Pancreatic Cancer. (NCT04632303) | Inna Chen, MD | 2021-06-23 |
| An Unusual Association Between Pancreatic Cancer and Purtscher-like Retinopathy (NCT05350384) | University of Catania | 2021-06-18 |
| Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer (NCT04327986) | National Cancer Institute (NCI) | 2021-06-15 |
| Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma (NCT04662112) | Asan Medical Center | 2021-06-15 |
| Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) (NCT04498767) | European Organisation for Research and Treatment of Cancer - EORTC | 2021-06-10 |
| Study of XB002 in Subjects With Solid Tumors (JEWEL-101) (NCT04925284) | Exelixis | 2021-06-07 |
| Organoid-Guided Adjuvant Chemotherapy for Pancreatic Cancer (NCT04931394) | Changhai Hospital | 2021-06-01 |
| Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis (NCT04807972) | AbbVie | 2021-05-28 |
| XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer (NCT04825288) | XBiotech, Inc. | 2021-05-27 |
| Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling (NCT05132868) | Stanford University | 2021-05-25 |
| Second Opinions in Oncology (NCT05102500) | University of Colorado, Denver | 2021-05-14 |
| Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer (NCT04634539) | Jun Gong, MD | 2021-05-13 |
| A Multi-center Study on the Efficacy and Safety of AI-assisted Navigation System for Biliopancreatic EUS (NCT04892329) | Renmin Hospital of Wuhan University | 2021-05-12 |
| To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic Ultrasound (NCT04834505) | Peking Union Medical College Hospital | 2021-05-11 |
| Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia (NCT04803305) | Pfizer | 2021-05-11 |
| Study of a New Technique for Imaging Pancreatic Cancer (NCT04883775) | Memorial Sloan Kettering Cancer Center | 2021-05-10 |
| ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study (NCT04431258) | Ability Pharmaceuticals SL | 2021-05-06 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| Gut Microbiota and Metabolite Signatures Associated With Lymph Node Metastasis in Pancreatic Cancer (NCT07161921) | Peking Union Medical College Hospital | 2021-05-01 |
| Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours (NCT04808362) | Peptomyc S.L. | 2021-04-28 |
| Nutritional Problems in Pallative Cancer (NCT04846985) | Jens Rikardt Andersen | 2021-04-26 |
| Efficacy and Safety of SHR-1020 Combined With Albumin-bound Paclitaxel in the Second-line Treatment of Pancreatic Cancer (NCT04814485) | Tianjin Medical University Cancer Institute and Hospital | 2021-04-22 |
| RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer (NCT04338763) | Rise Biopharmaceuticals, Inc. | 2021-04-19 |
| A Clinical Study of BRCA and DNA Damage Repair Genes in Blood Samples of Chinese Pancreatic Cancer Patients (NCT05138302) | RenJi Hospital | 2021-04-19 |
| PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine (NCT05697198) | Labcorp Corporation of America Holdings, Inc | 2021-04-19 |
| Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer (NCT03718650) | H. Lee Moffitt Cancer Center and Research Institute | 2021-04-01 |
| Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) (NCT03460769) | M.D. Anderson Cancer Center | 2021-04-01 |
| Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors (NCT04764084) | Peking University Cancer Hospital & Institute | 2021-04-01 |
| PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples (NCT04683315) | Medical College of Wisconsin | 2021-04-01 |
| Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors (NCT03915678) | Institut Bergonié | 2021-03-31 |
| Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer (NCT05035147) | Tianjin Medical University Cancer Institute and Hospital | 2021-03-25 |
| A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors (NCT04731467) | Famewave Ltd. | 2021-03-19 |
| A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies (NCT04678648) | RasCal Therapeutics, Inc. | 2021-03-03 |
| Nutrition and Pharmacological Algorithm for Oncology Patients Study (NCT04155008) | Montefiore Medical Center | 2021-03-01 |
| Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers (NCT04464967) | NKGen Biotech, Inc. | 2021-03-01 |
| Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition (NCT04542291) | Washington University School of Medicine | 2021-02-25 |
| OH2 Oncolytic Viral Therapy in Pancreatic Cancer (NCT04637698) | Binhui Biopharmaceutical Co., Ltd. | 2021-02-02 |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors (NCT04660929) | Carisma Therapeutics Inc | 2021-02-02 |
| 'OLAP' (OLAparib Regulatory Post-marketing Surveillance) (NCT04553926) | AstraZeneca | 2021-02-01 |
| PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer (NCT04883450) | Kaiser Permanente | 2021-02-01 |
| Cardiopulmonary Exercise Testing: An Assessment of Patients Fitness for Palliative Chemotherapy for Pancreatic Cancer (NCT03215459) | The Clatterbridge Cancer Centre NHS Foundation Trust | 2021-02-01 |
| Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis (NCT05906615) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2021-01-14 |
| SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells (NCT04150042) | General Oncology, Inc. | 2021-01-13 |
| Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients (NCT06570174) | Yonsei University | 2021-01-07 |
| Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image Data (NCT05313854) | RenJi Hospital | 2021-01-01 |
| CE-IOUS for Patients With Pancreatic Cancer Undergoing Surgery: A Prospective, Proof-of-concept Trial (NCT04683497) | University of Thessaly | 2021-01-01 |
| Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 (NCT04805307) | Keymed Biosciences Co.Ltd | 2020-12-24 |
| Spanish Registry of Digestive Tumours RETUD (NCT06711211) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2020-12-23 |
| A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors (NCT04672460) | Pfizer | 2020-12-21 |
| A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer (NCT04425876) | Jiangsu HengRui Medicine Co., Ltd. | 2020-12-17 |
| LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors (NCT04666688) | PureTech | 2020-12-15 |
| RNA Precision Oncology in Advanced Pancreatic Cancer (NCT04476537) | Columbia University | 2020-12-07 |
| Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI) (NCT04743479) | Changhai Hospital | 2020-12-01 |
| Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer (NCT06195254) | Peking University Third Hospital | 2020-12-01 |
| A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer (NCT04571489) | Lee's Pharmaceutical Limited | 2020-12-01 |
| Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers (NCT04330716) | Dana-Farber Cancer Institute | 2020-12-01 |
| A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer (NCT04624217) | Jiangsu HengRui Medicine Co., Ltd. | 2020-11-24 |
| A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (NCT04477343) | University of Rochester | 2020-11-23 |
| Silicon Microsieve Device vs Cell Surface Marker-based Platform for the Isolation of Pancreatic Cancer CTCs (NCT04638868) | Singapore General Hospital | 2020-11-17 |
| LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent (NCT04595058) | Hospital Universitari de Bellvitge | 2020-11-17 |
| Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia. (NCT04299048) | Pfizer | 2020-11-17 |
| Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (NCT04644068) | AstraZeneca | 2020-11-12 |
| A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors (NCT04682431) | Ikena Oncology | 2020-11-10 |
| Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma (NCT04543071) | Gulam Manji | 2020-11-09 |
| Carbon Ion RT for Locally Advanced Pancreatic Cancer (NCT04592861) | Albert Einstein College of Medicine | 2020-11-01 |
| PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) (NCT04484636) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2020-10-28 |
| The PLATON Network (NCT05489250) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2020-10-28 |
| Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection (NCT04581473) | CARsgen Therapeutics Co., Ltd. | 2020-10-23 |
| Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers (NCT04404595) | CARsgen Therapeutics Co., Ltd. | 2020-10-23 |
| Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer (NCT04002479) | Alpha Tau Medical LTD. | 2020-10-20 |
| Tempus Priority Study: A Pan-tumor Observational Study (NCT05179824) | Tempus AI | 2020-10-19 |
| Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy (NCT04517448) | Centre Hospitalier de la côte Basque | 2020-10-16 |
| Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response (NCT04588025) | Ohio State University | 2020-10-14 |
| Recurrence After Whipple's (RAW) Study (NCT04596865) | University Hospital Plymouth NHS Trust | 2020-10-12 |
| Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE (NCT06849063) | Yu Shi | 2020-10-09 |
| A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) (NCT04504916) | VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2020-10-07 |
| CIRcular and Non-coding RNAs as Clinically USeful Biomarkers in Pancreaticobiliary Cancers (NCT04584996) | Royal Surrey County Hospital NHS Foundation Trust | 2020-10-04 |
| Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain (NCT04034745) | Andrew Hendifar, MD | 2020-10-01 |
| OMT-111 for Terminal Stage Solid Tumors (NCT04520386) | MetiMedi Pharmaceuticals | 2020-10-01 |
| Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors (NCT04383210) | Elevation Oncology | 2020-09-29 |
| Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics (NCT04584008) | Peking University | 2020-09-23 |
| Supportive Oncology Care At Home RCT (NCT04544046) | Massachusetts General Hospital | 2020-09-16 |
| COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer (NCT04257955) | IRCCS San Raffaele | 2020-09-15 |
| Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer (NCT04894643) | EBG MedAustron GmbH | 2020-09-14 |
| Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico (NCT05305001) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2020-09-09 |
| Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab (NCT04164069) | Anne Noonan | 2020-09-02 |
| Using Digestive Microbial Information to Enhance the Early Detection of Pancreatic Cancer (NCT05689138) | Peking Union Medical College Hospital | 2020-09-01 |
| PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer (NCT04612530) | Amsterdam UMC, location VUmc | 2020-09-01 |
| ERAS Protocol in Pancreaticoduodenectomy and Total Pancreatectomy (NCT03757455) | Tampere University Hospital | 2020-09-01 |
| Biomarkers of Pancreatic Cancer and New Way to Detection (NCT04549064) | First Affiliated Hospital Xi'an Jiaotong University | 2020-09-01 |
| BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours (NCT04421820) | Bold Therapeutics, Inc. | 2020-08-28 |
| PEG-rhG-CSF in Secondary Prevention of Nab-Paclitaxel Combined With S-1 in Advanced Pancreatic Cancer (NCT04518800) | Chinese PLA General Hospital | 2020-08-18 |
| Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma (NCT04157127) | Diakonos Oncology Corporation | 2020-08-03 |
| Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer (NCT05400681) | Sonke Detlefsen | 2020-08-01 |
| A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009） (NCT04420130) | Yanqiao Zhang | 2020-08-01 |
| A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer (NCT03519308) | Abramson Cancer Center at Penn Medicine | 2020-07-29 |
| Niraparib + Dostarlimab + RT in Pancreatic Cancer (NCT04409002) | Massachusetts General Hospital | 2020-07-23 |
| Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer (NCT04390399) | ImmunityBio, Inc. | 2020-07-21 |